PANACEABIOPanacea Biotec Limited
Pharma · Biotechnology · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹548.85
0.00%Average
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)3,361.70
P/E—
P/B4.27
PEG—
ROE %-0.60
ROCE %-4.40
Debt / Equity0.03
EPS-0.86
Revenue Growth %1.00
Profit Growth %-12.20
Dividend Yield %0.00
Promoter Holding %72.65
FII Holding %0.13
DII Holding %—
Beta0.14
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹548.85 | ₹521.90 | ₹615.85 | 2.49 |
HOLDConviction 55%
The picture
- • Debt/Equity: 0.03
- • Promoter holding: 72.7%
- • RSI: 55
- • Price vs EMA21: above
- • Price vs SMA50: above
- • 3-month return: +50.9%
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • Debt/Equity: 0.03
- • Promoter holding: 72.7%
- • RSI: 55
- • Price vs EMA21: above
Bear case
- • Revenue growth: 1.0% YoY
- • Profit growth: -12.2% YoY
- • MACD: bearish
- • Volume: 0.3x 20-day average
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 1.0% YoY
- • Profit growth: -12.2% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹548.85
Stop Loss
₹515.05
risk 6.2%
Target 1 (1.5R)
₹599.55
+9.2%
Target 2 (3R)
₹650.26
+18.5%
Support (20d)
₹520.25
Resistance (52w)
₹647.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹33.80/share
ATR (volatility)
₹26.95
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹26.95). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
27
Technical
66
Momentum
74
Risk (safety)
40